期刊文献+

AZT对白血病细胞株KG-1a细胞增殖和端粒酶活性的影响 被引量:4

Effects of AZT on Leukemia Cell Line KG-1a Proliferation and Telomerase Activity
下载PDF
导出
摘要 本研究探索端粒酶抑制剂3'-叠氮-2',3'-脱氧胸腺核苷(AZT)对人急性髓系白血病细胞株KG-1a细胞增殖和端粒酶活性的影响。用MTT法检测不同浓度AZT分别作用24、48、72 h时KG-1a细胞增殖水平;流式细胞术检测AZT对KG-1a细胞周期及细胞凋亡的影响;TRAP-PCR-ELISA法检测细胞端粒酶活性;RT-PCR法检测细胞端粒逆转录酶(hTERT)mRNA的表达。结果表明,AZT能抑制KG-1a细胞增殖,抑制作用具有时间和浓度依赖性;随AZT浓度的增加,处于S期的细胞数目减少,G2/M期细胞数目增加,且出现凋亡峰;AZT作用后实验组细胞的端粒酶活性降低,hTERT-mRNA表达下降,下调程度与AZT浓度呈正相关。结论:AZT在体外能明显抑制KG-1a细胞增殖,并诱导其凋亡,其机制与降低端粒酶活性、下调hTERT mRNA表达有关。 This study was purposed to investigate the effect of 3′-azido-2′,3′-dideoxythymidine(AZT)on the proliferation and telomerase activity of human acute myeloid leukemia cell line KG-1a.The effect of proliferation was detected by MTT assay after the KG-1a cell were stimulated for 24,48 and 72 h with different concentrations of AZT;telomerase activity was detected with TRAP-PCR-ELISA assay;RT-PCR was used to detect telomerase hTERT mRNA expression.The results showed that the proliferation of KG-1a cells was inhibited in a time and concentration dependent manner after exposure to AZT for 24,48 and 72 h;the KG-1a cells decreased in S phase and increased in G2/M phase with the increasing of the concentration of AZT;telomerase activity and hTERT-mRNA expression in the experimental groups decreased after treated with AZT,which was positilvely correlated with concentration of AZT.It is concluded that AZT inhibits KG-1a cell proliferation and induces apoptosis,which maybe related with its decreasing the telomerase activity and hTERT mRNA expression.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2012年第2期277-281,共5页 Journal of Experimental Hematology
基金 2010甘肃省财政厅基本科研业务费专用资金(编号甘政财〔2010〕176号) 2011年甘肃省普通中医药科研立项资助课题G2K-2011-69
关键词 白血病 KG-1a细胞 AZT 端粒酶 leukemia KG-1a cell AZT telomerase
  • 相关文献

参考文献10

  • 1Berman AJ, AkJyama BM, Stone MD, et al. The RNA accordion model for template positioning by telomerase RNA during telomeric DNA synthesis. Nat Struct Mol Biol,2011 ;18(12) : 1371 - 1375.
  • 2Yu S, Zhang JZ, Zhao CL, et al. Isolation and characterization of CD133 Precursors from the ventricular zone of hunman fetal brain by magnetic affinity cell sorting. Biotechnol Lett,2004;26 (14) : 1131 - 1136.
  • 3Sharp NE, DePinho RA. Telomeres, stem cells, senescence, and cancer. J Clin Invest .2004:113(2) :160 -168.
  • 4Mattiussi M, Tilman G, Lenqlez S, et al. Human telomerase represses ROS-dependent cellular responses to Tumor Necrosis Factor-a without affecting NF-Kb activation. Cell Signal,2011 ; 13 (9) :459 -461.
  • 5金洁,王蕾,钱文斌,孟海涛.小剂量高三尖杉酯碱对K562细胞端粒酶活性及其分化的影响[J].中华血液学杂志,2003,24(11):611-613. 被引量:4
  • 6Bley CJ, Qi X, Rand DP, et al. RNA-protein binding interface in the telomerase dbonucleoprotein. Proc Nat Acad Sci USA,2011 ;28 (9) :569 -731.
  • 7何敏,蒋玉艳,朱淼,韦霄,覃健,张志勇,李力.AZT对肝癌细胞端粒酶活性及相关蛋白表达的影响[J].癌症,2006,25(5):543-548. 被引量:6
  • 8陈雯,张桥,魏青,吴大伟,邓丽霞,万德森中山医科大学肿瘤医院腹外科.端粒酶抑制剂对肿瘤细胞及其端粒酶活性的影响[J].肿瘤,2000,20(6):415-418. 被引量:12
  • 9Dhaene K, Van Marok E, Paiwaresch R, et al. Telomeres, telomerase and cancer: an update. Virchows Arch,2000;437( 1 ) : 1 -16.
  • 10Akiyama M, Yamada N, Kanda N, et al. Telomerase overexprossinu in K562 leukemia ceils protects against apoptosis by serum deprivation and double stranded DNA break inducing agents, but not against DNA synthesis inhibitors. Cancer Lett, 2002;178 (2) :187 - 197.

二级参考文献20

  • 1蒋玉艳,何敏,杨莉,何晓.端粒酶抑制剂诱导肝癌SMMC-7721细胞凋亡的研究[J].中华综合临床医学杂志(北京),2004,6(11):1-4. 被引量:4
  • 2[1]Shay JW, Bacchetti S. A survey of telomerase activity in human cancer[J]. Eur J Cancer,1997,33:787
  • 3[2]Reynolds T. First antisense drug trial planned in leukemia[J]. J Natl Cancer Inst,1992,84:288
  • 4[3]Villahermosa ML,Martinez-Irujo JJ, Cabodevilla F, et al. Synergistic inhibition of HIV-1 reverse transcriptase by combinations of chain-terminating nucleotides[J]. Biochemistry, 1997,36:13223
  • 5[4]Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer[J]. Science, 1994,266:2011
  • 6[5]Kim NW, Wu F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol(TRAP)[J].Nucleic Acid Res,1997,25:2595
  • 7[6]Stella MM, Holland JF, Pogo BGT. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3′-azido-3′-deoxythymidine[J].Clin Cancer Res,1998,4:693
  • 8[7]Daniel EG,Tejera AM, Olive OA. Irreversible telomere shortening by 3′-azido-2′,3′-dideoxythmidine(AZT) treatment[J]. Biochem Biophy Res Commun,1998,246:107
  • 9[8]Seiji K, Yoshikazu T, Yasuko K, et al. Antisense telomerase treatment:induction of two distinct pathways, apoptosis and differentiation. FASEB J, 1998,12:801
  • 10Sugimoto T, Tsukamato F, Fujita M, et al. Ki-ras and c-myc oncogene expression measured by coamplification polymerase chain reaction. Biochem Biophys Res Commun, 1994, 201: 574-580.

共引文献18

同被引文献77

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部